Nutritional Intervention for Sustaining Health (NURISH) Trial
Launched by UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · May 24, 2024
Trial Information
Current as of February 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The purpose of this study is to understand how a healthy diet is related to thinking ability and heart health. Participants will be asked to consume a microwaveable study meal or prepackaged smoothie every day for 12 weeks. These meals will be delivered to participant homes using Daily Harvest meal delivery service. The study meals and smoothies will follow either a dietary pattern thought to improve brain and heart health (MIND), or a control diet, and will include foods commonly found in grocery stores. Participants will not know which diet they are assigned to (active or control). Partic...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 45-64 years of age
- • 20/20 or corrected vision
- • No food allergies or intolerances
- • Not pregnant, lactating, or have given birth in the past 12 months
- • Do not smoke, use tobacco, or abuse drugs
- • Absence of liver or gastrointestinal diseases (i.e., primary biliary cirrhosis or gallbladder disease, chronic constipation, diarrhea, Crohn's disease, celiac disease, ulcerative colitis, irritable bowel syndrome, diverticulosis, stomach or duodenal ulcers), hepatitis, HIV, and cancer
- • Not currently taking oral hypoglycemic agents, or insulin
- • No history of malabsorptive or bariatric surgery
- • Cognitively intact with no prior diagnosis of neurological disease (i.e., mild cognitive impairment, Alzheimer's disease, vascular dementia, and/or Asperger's syndrome)
- • Able to consume the study meals
- • Not enrolled in another dietary, exercise, or medication study during the study
- Exclusion Criteria:
- • Non-consent of participant
- • Above 64 or below 45 years of age
- • Vision not 20/20 or corrected
- • Food allergies or intolerances
- • Pregnant, lactating, or have given birth in the past 12 months
- • Smoke, use tobacco, or abuse drugs
- • Prior diagnosis of liver or gastrointestinal disease (i.e., primary biliary cirrhosis or gallbladder disease, chronic constipation, diarrhea, Crohn's disease, celiac disease, ulcerative colitis, irritable bowel syndrome, diverticulosis, stomach or duodenal ulcers), hepatitis, HIV, or cancer
- • Currently taking oral hypoglycemic agents or insulin
- • History of malabsorptive or bariatric surgery
- • Cognitively impaired and/or prior diagnosis of neurological disease (i.e., mild cognitive impairment, Alzheimer's disease, vascular dementia, and/or Asperger's syndrome)
- • Unable to consume the study meals
- • Concurrent enrollment in another dietary, exercise, or medication study
Trial Officials
Naiman Khan, PhD
Principal Investigator
University of Illinois Urbana-Champaign
About University Of Illinois At Urbana Champaign
The University of Illinois at Urbana-Champaign is a leading research institution dedicated to advancing knowledge and innovation in various fields, including health sciences. With a strong commitment to rigorous scientific inquiry, the university conducts clinical trials aimed at improving patient outcomes and understanding complex health challenges. Leveraging its multidisciplinary expertise and state-of-the-art facilities, the university collaborates with healthcare professionals and researchers to explore novel therapeutic interventions and enhance evidence-based practices. Through its clinical trials, the University of Illinois at Urbana-Champaign strives to contribute significantly to the advancement of medical science and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0